ENTITY

LianBio (LIAN US)

15

Analysis

Health Care • United States

LianBio operates as a biological technology company. The Company develops therapies to treat cardiovascular, oncology, respiratory, ophthalmology and inflammatory disease. LianBio serves customers patients in Asia.

more

Refresh

Exchange Announcement • 13 Feb 2024 20:04

Current Report (Form 8-K | Period ending 2024-02-09)

Exchange Announcement • 08 Jan 2024 19:13

Notice of proposed sale of securities pursuant to Rule 144 (PDF)

Exchange Announcement • 29 Dec 2023 20:56

Notice of proposed sale of securities pursuant to Rule 144 (PDF)

Exchange Announcement • 27 Dec 2023 05:10

Initial statement of beneficial ownership of securities - general instructions (PDF)

Exchange Announcement • 27 Dec 2023 05:07

Current report pursuant to Section 13 or 15(d) (PDF)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x